Genpharmasec share news, announcements and annual reports
BSE: 531592Commercial Services & SuppliesSmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.99.
2 Nov: open ₹1.00, high ₹1.03, low ₹0.98
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹56 Cr3,222nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −1.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.50
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,52,702
Genpharmasec share news and announcements
611 announcements, routine notices left out, newest first. Page 4 of 13.
May 2023
8 May · Board meeting
3 May · Board meeting
Meeting on 8 May 2023: increase in authorised capital
Apr 2023
24 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
18 Apr · Non-Applicability Of Regulation 32 Of SEBI (LODR), 2015 For The Year Ended March 31, 2023
18 Apr · Certificate Under Regulation 40(10) Of SEBI (LODR), 2015 For The Year Ended March 31, 2023
10 Apr · Compliance Certificate For The Year Ended March'2023
10 Apr · Compliance-57 (5) : intimation after the end of quarter
10 Apr · Compliance-57 (4) : Prior intimation to the beginning of the quarter
Mar 2023
30 Mar · Board meeting
10 Mar · Providing Missed Information Of Independent Director Who Had Resigned On November 1, 2022
10 Mar · Providing Missed Information Of Independent Director Who Had Resigned On October 4, 2022
Feb 2023
2 Feb · Board meeting
Meeting on 10 Feb 2023: quarterly results
Jan 2023
17 Jan · Providing Missed Information Of 2 Independent Director Who Had Resigned On June 21, 2022
Dec 2022
28 Dec · Meeting
20 Dec · Board meeting
Meeting on 28 Dec 2022
Nov 2022
3 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results2 Nov · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Order Passed By SEBI Against Satellite Corporate Services Pvt. Ltd., Registrar And Share Transfer Agent Of The Company.
Oct 2022
27 Oct · Board meeting
Meeting on 1 Nov 202210 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
5 Sep · Board meeting
Aug 2022
10 Aug · Board meeting
10 Aug · Board meeting